Literature DB >> 33920673

Structural and Functional Remodeling of Mitochondria in Cardiac Diseases.

Xiaonan Sun1, Jalen Alford1, Hongyu Qiu1.   

Abstract

Mitochondria undergo structural and functional remodeling to meet the cell demand in response to the intracellular and extracellular stimulations, playing an essential role in maintaining normal cellular function. Merging evidence demonstrated that dysregulation of mitochondrial remodeling is a fundamental driving force of complex human diseases, highlighting its crucial pathophysiological roles and therapeutic potential. In this review, we outlined the progress of the molecular basis of mitochondrial structural and functional remodeling and their regulatory network. In particular, we summarized the latest evidence of the fundamental association of impaired mitochondrial remodeling in developing diverse cardiac diseases and the underlying mechanisms. We also explored the therapeutic potential related to mitochondrial remodeling and future research direction. This updated information would improve our knowledge of mitochondrial biology and cardiac diseases' pathogenesis, which would inspire new potential strategies for treating these diseases by targeting mitochondria remodeling.

Entities:  

Keywords:  heart disease; heart failure; metabolism; mitochondria remodeling

Year:  2021        PMID: 33920673     DOI: 10.3390/ijms22084167

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  10 in total

1.  Targeting calcium-mediated inter-organellar crosstalk in cardiac diseases.

Authors:  Mohit M Hulsurkar; Satadru K Lahiri; Jason Karch; Meng C Wang; Xander H T Wehrens
Journal:  Expert Opin Ther Targets       Date:  2022-04-25       Impact factor: 6.797

2.  The potential of remdesivir to affect function, metabolism and proliferation of cardiac and kidney cells in vitro.

Authors:  Katja Merches; Leonie Breunig; Julia Fender; Theresa Brand; Vanessa Bätz; Svenja Idel; Laxmikanth Kollipara; Yvonne Reinders; Albert Sickmann; Angela Mally; Kristina Lorenz
Journal:  Arch Toxicol       Date:  2022-05-17       Impact factor: 6.168

3.  Functional Inhibition of Valosin-Containing Protein Induces Cardiac Dilation and Dysfunction in a New Dominant-Negative Transgenic Mouse Model.

Authors:  Xiaonan Sun; Ning Zhou; Ben Ma; Wenqian Wu; Shaunrick Stoll; Lo Lai; Gangjian Qin; Hongyu Qiu
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

Review 4.  Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation.

Authors:  Xiaoli Tang; Zengwu Wang; Shengshou Hu; Bingying Zhou
Journal:  Pharmaceutics       Date:  2022-06-21       Impact factor: 6.525

5.  Vaspin Ameliorates Cardiac Remodeling by Suppressing Phosphoinositide 3-Kinase/Protein Kinase B Pathway to Improve Oxidative Stress in Heart Failure Rats.

Authors:  Mingyue Ji; Yong Li; Yun Liu; Genshan Ma
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

6.  Tumstatin (69-88) alleviates heart failure via attenuating oxidative stress in rats with myocardial infarction.

Authors:  Congfei Zhu; Zhi Zuo; Cheng Xu; Mingyue Ji; Junjie He; Jinshuang Li
Journal:  Heliyon       Date:  2022-09-12

7.  Vanillic acid attenuates H2O2-induced injury in H9c2 cells by regulating mitophagy via the PINK1/Parkin/Mfn2 signaling pathway.

Authors:  Manxue Mei; Haoxiang Sun; Jiayu Xu; Yimeng Li; Guiling Chen; Qihua Yu; Changsheng Deng; Wei Zhu; Jianping Song
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

8.  Cardiac Mitochondria Dysfunction in Dyslipidemic Mice.

Authors:  Alicja Braczko; Barbara Kutryb-Zajac; Agata Jedrzejewska; Oliwia Krol; Paulina Mierzejewska; Magdalena Zabielska-Kaczorowska; Ewa M Slominska; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

Review 9.  Therapeutic non-invasive brain treatments in Alzheimer's disease: recent advances and challenges.

Authors:  Chongyun Wu; Luoman Yang; Shu Feng; Ling Zhu; Luodan Yang; Timon Cheng-Yi Liu; Rui Duan
Journal:  Inflamm Regen       Date:  2022-10-03

10.  PINK1 Phosphorylates Drp1S616 to Improve Mitochondrial Fission and Inhibit the Progression of Hypertension-Induced HFpEF.

Authors:  Jian Shou; Yunlong Huo
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.